Xixi Cheng

868 total citations
15 papers, 621 citations indexed

About

Xixi Cheng is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pharmacology. According to data from OpenAlex, Xixi Cheng has authored 15 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 3 papers in Pharmacology. Recurrent topics in Xixi Cheng's work include Parasitic infections in humans and animals (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Liver physiology and pathology (2 papers). Xixi Cheng is often cited by papers focused on Parasitic infections in humans and animals (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Liver physiology and pathology (2 papers). Xixi Cheng collaborates with scholars based in China, Australia and France. Xixi Cheng's co-authors include Rongxin Zhang, Zhenyi Xue, Yurong Da, Zhi Yao, Bingqing Huang, Huafeng Wang, Fei Gao, Qi Zhang, Shuyu Fu and Liang Qiao and has published in prestigious journals such as Cancer Research, Scientific Reports and Cancer Letters.

In The Last Decade

Xixi Cheng

14 papers receiving 615 citations

Peers

Xixi Cheng
Xixi Cheng
Citations per year, relative to Xixi Cheng Xixi Cheng (= 1×) peers Yoshiaki Matsumi

Countries citing papers authored by Xixi Cheng

Since Specialization
Citations

This map shows the geographic impact of Xixi Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xixi Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xixi Cheng more than expected).

Fields of papers citing papers by Xixi Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xixi Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xixi Cheng. The network helps show where Xixi Cheng may publish in the future.

Co-authorship network of co-authors of Xixi Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xixi Cheng. A scholar is included among the top collaborators of Xixi Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xixi Cheng. Xixi Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Wang, Liying, Zhiyi Wang, Min Qin, et al.. (2024). A regressive analysis of the main environmental risk factors of human echinococcosis in 370 counties in China. PLoS neglected tropical diseases. 18(5). e0012131–e0012131. 2 indexed citations
3.
4.
Qin, Min, Liying Wang, Xu Wang, et al.. (2023). Investigation on the Management for Patients with Echinococcosis Treated with Albendazole — Three PLADs, China, 2019. China CDC Weekly. 5(20). 437–441. 2 indexed citations
5.
Wang, Liying, Min Qin, Laurent Gavotte, et al.. (2022). Societal drivers of human echinococcosis in China. Parasites & Vectors. 15(1). 385–385. 11 indexed citations
6.
Cheng, Xixi, et al.. (2022). Investigation on the fretting wear behavior of titanium alloy under different atmospheres by an in situ XPS spectrometry. International Journal of Modern Physics B. 36(19). 2 indexed citations
7.
Cheng, Xixi, Huafeng Wang, Jinlai Yang, et al.. (2018). Arctigenin protects against liver injury from acute hepatitis by suppressing immune cells in mice. Biomedicine & Pharmacotherapy. 102. 464–471. 17 indexed citations
9.
Huang, Bingqing, Huipeng Yang, Xixi Cheng, et al.. (2017). tRF/miR-1280 Suppresses Stem Cell–like Cells and Metastasis in Colorectal Cancer. Cancer Research. 77(12). 3194–3206. 201 indexed citations
10.
Wang, Huafeng, Huan Zhang, Zimu Zhang, et al.. (2016). Adiponectin-derived active peptide ADP355 exerts anti-inflammatory and anti-fibrotic activities in thioacetamide-induced liver injury. Scientific Reports. 6(1). 19445–19445. 59 indexed citations
11.
Wang, Dan, Huafeng Wang, Shuyu Fu, et al.. (2016). Parthenolide ameliorates Concanavalin A-induced acute hepatitis in mice and modulates the macrophages to an anti-inflammatory state. International Immunopharmacology. 38. 132–138. 19 indexed citations
12.
Huang, Biao, Xixi Cheng, Huafeng Wang, et al.. (2016). Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. Journal of Translational Medicine. 14(1). 45–45. 139 indexed citations
13.
Wang, Huafeng, Yuqing Zhang, Dan Wang, et al.. (2016). Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production. Oncotarget. 7(50). 82864–82875. 35 indexed citations
14.
Huang, Bingqing, Xixi Cheng, Dan Wang, et al.. (2014). Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/Sirt1/PGC-1α signaling. Oncotarget. 5(13). 4732–4745. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026